In a significant move affecting international commerce, the United States Postal Service has implemented a suspension on incoming package deliveries from China and Hong Kong, impacting major online retailers like…
65 search results for “trade”
Global markets experienced significant turbulence on Monday as President Donald Trump’s sweeping new tariff announcements rattled investors and sparked concerns of an impending trade war. The measures, which will affect…
Financial markets experienced a modest retreat Friday from their recent record highs, as investors processed President Donald Trump’s evolving stance on international trade tariffs. The shift in market sentiment followed…
Major technology companies are taking preemptive measures in response to Donald Trump’s proposed trade policies, even before his anticipated return to the White House. The president-elect’s plans to implement substantial…
Financial markets faced significant downward pressure Friday as political turmoil in Washington pushed major indices toward their poorest weekly performance of the year. The tumult centered around complications with a…
Financial markets showed resilience Tuesday morning despite President-elect Donald Trump’s unexpected announcement of potential new tariffs, with U.S. stock futures indicating modest gains at the opening bell. In a late…
Following former President Donald Trump’s electoral victory over Vice President Kamala Harris in the 2024 presidential election, BMW’s chief executive has expressed optimism about potential trade policies that could affect…
U.S. Senators Ted Cruz and John Cornyn of Texas have announced the successful acquisition of a presidential permit for the Laredo 4/5 International Bridge in Webb County. This development marks…
The housing market faces mounting challenges in 2025 as potential homebuyers navigate multiple obstacles, from elevated interest rates to increasing home prices and limited inventory. While mortgage rates remain a…
Silexion Therapeutics* (NASDAQ: SLXN) is making strides in oncology with its RNAi-based treatment, SIL-204, targeting KRAS-driven cancers. In an interview on Market Leaders, CEO Ilan Hadar discussed the company’s recent…
Can't find what you're looking for? Try refining your search: